Shavva Vladimir S, Bogomolova Alexandra M, Nikitin Artemy A, Dizhe Ella B, Oleinikova Galina N, Lapikov Ivan A, Tanyanskiy Dmitry A, Perevozchikov Andrej P, Orlov Sergey V
Department of Biochemistry, Institute of Experimental Medicine, Russian Academy of Medical Sciences, Acad. Pavlov St., 12, St. Petersburg, 197376, Russia.
Department of Embryology, St. Petersburg State University, St. Petersburg, Russia.
Cell Stress Chaperones. 2017 Jan;22(1):123-134. doi: 10.1007/s12192-016-0749-6. Epub 2016 Nov 28.
Reactive oxygen species damage various cell components including DNA, proteins, and lipids, and these impairments could be a reason for severe human diseases including atherosclerosis. Forkhead box O1 (FOXO1), an important metabolic transcription factor, upregulates antioxidant and proapoptotic genes during oxidative stress. Apolipoprotein A-I (ApoA-I) forms high density lipoprotein (HDL) particles that are responsible for cholesterol transfer from peripheral tissues to liver for removal in bile in vertebrates. The main sources for plasma ApoA-I in mammals are liver and jejunum. Hepatic apoA-I transcription depends on a multitude of metabolic transcription factors. We demonstrate that ApoA-I synthesis and secretion are decreased during HO-induced oxidative stress in human hepatoma cell line HepG2. Here, we first show that FOXO1 binds to site B of apoA-I hepatic enhancer and downregulates apoA-I gene activity in HepG2 cells. Moreover, FOXO1 and LXRα transcription factors participate in HO-triggered downregulation of apoA-I gene together with Src, JNK, p38, and AMPK kinase cascades. Mutations of sites B or C as well as the administration of siRNAs against FOXO1 or LXRα to HepG2 cells abolished the hydrogen peroxide-mediated suppression of apoA-I gene.
活性氧会损伤包括DNA、蛋白质和脂质在内的各种细胞成分,而这些损伤可能是包括动脉粥样硬化在内的严重人类疾病的一个原因。叉头框O1(FOXO1)是一种重要的代谢转录因子,在氧化应激期间会上调抗氧化和促凋亡基因。载脂蛋白A-I(ApoA-I)形成高密度脂蛋白(HDL)颗粒,在脊椎动物中负责将胆固醇从外周组织转运到肝脏以便通过胆汁排出。哺乳动物血浆ApoA-I的主要来源是肝脏和空肠。肝脏载脂蛋白A-I的转录依赖于多种代谢转录因子。我们证明,在人肝癌细胞系HepG2中,HO诱导的氧化应激期间载脂蛋白A-I的合成和分泌减少。在此,我们首先表明FOXO1与载脂蛋白A-I肝脏增强子的B位点结合,并下调HepG2细胞中载脂蛋白A-I基因的活性。此外,FOXO1和LXRα转录因子与Src、JNK、p38和AMPK激酶级联反应一起参与HO触发的载脂蛋白A-I基因下调。对HepG2细胞的B或C位点进行突变以及给予针对FOXO1或LXRα的小干扰RNA,消除了过氧化氢介导的对载脂蛋白A-I基因的抑制作用。